BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management


6/27/2008 10:43:13 AM

HYDERABAD, India and WESTBOROUGH, Mass., June 26 /PRNewswire-FirstCall/ -- Satyam Computer Services Ltd. , a leading global consulting and information technology services provider, announced today that it has formed an alliance with Sciformix Corporation, a Westborough, Mass.-based, Life Science Knowledge Process Outsourcing (KPO) company, to deliver end-to-end data management services in "Pharmacovigilance."

The partnership addresses the worldwide increase in focus on drug safety, which is leading to increased volumes of adverse events being reported to the regulatory authorities. Satyam and Sciformix will collaborate to enable pharmaceutical and biotechnology companies to better monitor the safety of the products they market by offering services across the safety management spectrum, ranging from case intake to international regulatory reporting. The alliance also enables the organizations to offer these services in a way that is both cost-efficient and scalable, via a proven global delivery model.

Additionally, the alliance leverages Sciformix's in-depth understanding of the pharmaceutical and life sciences domain with Satyam's proven drug safety Business Process Outsourcing (BPO) capabilities. It will provide services to a wide range of clients in the pharmaceutical, biotechnology and life sciences industries.

"We are very pleased by this partnership. Sciformix has deep expertise delivering end-to-end safety management services, from adverse event intake to regulatory submissions," said Kishore Rachapudi, Satyam's global head of life sciences. "We will leverage our extensive experience managing large-scale IT and BPO solutions and work with Sciformix to offer a scalable platform for delivery of drug safety services. At the same time, we reaffirm our commitment to providing the widest range of services through the most advanced global delivery models available."

Several high-profile withdrawals of popular drugs from the marketplace have also made this partnership more important. The withdrawals have pharmaceutical companies looking for ways to manage risk and taking a more proactive approach toward collection and assessment of drug safety information.

"These are some of the most important reasons we have formed this partnership," said Dinesh Thakur, president and Chief Executive Officer of Sciformix, "Satyam brings years of experience delivering outsourced services to global customers. Its large-scale global delivery services capacity and experience in the life sciences industry, along with Sciformix's deep domain expertise, offer global pharmaceutical, biotechnology and life sciences companies a unique alliance for delivery of high-quality services."

About Satyam

Satyam , a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and 63* countries.

Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company's 51,127* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities.

Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 654* clients, including more than one third of the Fortune 500. For more information, see www.satyam.com.

*As of March 31, 2008

About Sciformix Corporation

Founded in the U.S. with headquarters in Westborough, MA, and a Pharmacovigilance Center of Excellence in Mumbai, India, Sciformix is a fast growing knowledge process outsourcing (KPO) company providing drug safety data management, clinical data management, biostatistics & programming and medical writing services to pharmaceutical, biotechnology and life science companies globally. Sciformix has an experienced leadership team driving its rapid growth and expansion. For more information on Sciformix, please visit www.sciformix.com.

Safe Harbor

This press release contains forward-looking statements within the meaning of section 27A of Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward- looking statements. Satyam undertakes no duty to update any forward-looking statements. For a discussion of the risks associated with our business, please see the discussions under the heading "Risk Factors" in our report on Form 6-K concerning the quarter ended December 31, 2007, furnished to the United States Securities Exchange Commission on January 28, 2008 and the other reports filed with the Securities Exchange Commission from time to time. These filings are available at http://www.sec.gov.

This announcement is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from Satyam and that will contain detailed information about Satyam and its management, as well as financial statements.

CONTACT: Rajiv Prasad, AVP Life Sciences of Satyam Computers Limited,
Rajiv_Prasad@satyambpo.com, or Jeffrey S. Yablon, Vice President, Sales &
Marketing of Sciformix Corporation, jeffrey.yablon@sciformix.com; Satyam
Contacts: India, Meigha Humbre, meigha_humbre@satyam.com, +91-970-360-8822
or Rachna Pandey, Rachna_pandey@satyam.com, +91-970-303-8743; US, Jim
Swords, james_swords@satyam.com, +1-703-877-2225; Europe, Sandeep Thawani,
sandeep_thawani@satyam.com, +44-20-7309-1037; Asia-Pacific, Dan Bleakman,
Dan@howorth.com.au, +61-439-408-484 or Reshma Wad Jain, Reshma@wer1.net,
+65-98-140-507

Web site: http://www.satyam.com/
http://www.sciformix.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES